Recent epidemiological data have shown that more than half of all new cases of type 1
diabetes occur in adults. Key genetic, immune, and metabolic differences exist between …

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at
the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay …

A substantial proportion of patients with adult-onset diabetes share features of both type 1
diabetes (T1D) and type 2 diabetes (T2D). These individuals, at diagnosis, clinically …

Adult-onset autoimmune (AOA) diabetes pathophysiology starts with immune changes,
followed by dysglycaemia and overt disease. AOA diabetes can occur as classic type 1 …

Context Partial remission (PR) in type 1 diabetes (T1D) is accompanied by downregulation
of the immune response. Programmed cell death-1 (PD-1) and its ligand (PD-L1) are …

Latent autoimmune diabetes in adults (LADA) is the most common form of autoimmune
diabetes diagnosed in adults. Similar to type 1 diabetes, the prevalence of LADA is impacted …

Abstract Latent Autoimmune Diabetes in Adults (LADA) is a type of diabetes mellitus often
overlooked in clinical practice for its dual resemblance to Type 1 Diabetes Mellitus (T1DM) …

Background Partial remission (PR) is a special stage in type 1 diabetes (T1D). The different
patterns of PR frequency, characteristics, and determinants in juvenile and adult patients are …

Context The long-term effects of dipeptidyl peptidase-4 inhibitors on β-cell function and
insulin sensitivity in latent autoimmune diabetes in adults (LADA) are unclear. Objective To …

Type 1 diabetes most commonly presents in adulthood, contrary to the widely held view that
it is a disease of childhood. Furthermore, a substantial proportion of cases of adult-onset …